Because of the great potential value for the treatment of NB, we performed proteome analysis by using SILAC labeling and LC-MS/MS analysis in perifosine treated AS cells (27), and ATXN3 was one of those genes whose expressions were increased significantly after perifosine treatment. The gene discussed is ATXN3; the disease is neuroblastoma.